A 64-year-old man with type 2 diabetes and established ischaemic heart disease remains above target with HbA1c 71 mmol/mol despite Metformin at maximu...

Question

A 64-year-old man with type 2 diabetes and established ischaemic heart disease remains above target with HbA1c 71 mmol/mol despite Metformin at maximum tolerated dose. According to NICE guidance, which additional agent would be preferred because of cardiovascular benefit?

Accepted Answer

Add an SGLT2 inhibitor with proven cardiovascular benefit

Answer

Add a Sulfonylurea (e.g. Gliclazide)

Answer

Add a DPP-4 inhibitor

Answer

Add a Thiazolidinedione

Answer

Switch to insulin monotherapy

uk-plab-1 MCQ (SBA): T2DM with cardiovascular disease

A 64-year-old man with type 2 diabetes and established ischaemic heart disease remains above target with HbA1c 71 mmol/mol despite Metformin at maximum tolerated dose. According to NICE guidance, which additional agent would be preferred because of cardiovascular benefit?